Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jingjun, Yan"'
Publikováno v:
The FEBS Journal
Up to 10-20% of patients with coronavirus disease 2019 (COVID-19) develop a severe pulmonary disease due to immune dysfunction and cytokine dysregulation. However, the extracellular proteomic characteristics in respiratory tract of these critical COV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb21aaf70220442fa047abc086e162b
https://doi.org/10.1111/febs.15609
https://doi.org/10.1111/febs.15609
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 18, Iss, Pp 308-319 (2019)
Molecular Therapy: Nucleic Acids, Vol 18, Iss, Pp 308-319 (2019)
Growing tumor cells possess a distinct metabolic phenomenon that allows them to preferentially utilize glucose through aerobic glycolysis, which is referred to as the “Warburg effect.” Accumulating evidence suggests that microRNAs (miRNAs) could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5888b1114978b86d584f8a7c32aead81
http://europepmc.org/articles/PMC6796743
http://europepmc.org/articles/PMC6796743
Autor:
Pei-Yuan Li, Ying Chang, Ju-Sheng Lin, Kun-peng Ke, Yu-Nan Zhang, Jingjun Yan, Xing-Xing He, Min Wang, Jiazhi Liao
Publikováno v:
Oncotarget
Hepatocellular carcinoma (HCC) is a worldwide malignance and displays marked vascular abnormalities and active metastasis. MicroRNAs (miRNAs) have been shown to play important roles in regulating tumor properties in cancer, however, whether miR-497 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b94951f239762984be6b6e1206a8cca9
https://doi.org/10.18632/oncotarget.5012
https://doi.org/10.18632/oncotarget.5012
Publikováno v:
Tumor Biology. 37:807-815
The tumor suppressor p53 is one of the most frequently mutated genes in hepatocellular carcinoma (HCC). Previous studies demonstrated that CP-31398 restored the native conformation of mutant p53 and trans-activated p53 downstream genes in tumor cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2989d9c8d3c772ac21452e708eed634c
https://doi.org/10.1007/s13277-015-3857-5
https://doi.org/10.1007/s13277-015-3857-5
Autor:
Qian Wu, Yuhu Song, Ying Chang, Jingjun Yan, Junwei Yan, Fang Liu, Qian Dou, Xinjuan Kong, Yu-Nan Zhang, Xing-Xing He, Haitao Shang
Publikováno v:
Tumor Biology. 36:1437-1444
Rescuing the function of mutant p53 protein is an attractive cancer therapeutic strategy. Small molecule CP-31398 was shown to restore mutant p53 tumor suppressor functions in cancer cells. Here, we determined the effects of CP-31398 on the growth of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f476b069260773e2612123984422e3c
https://doi.org/10.1007/s13277-014-2389-8
https://doi.org/10.1007/s13277-014-2389-8
Autor:
Shuzhen Sun1,2 (AUTHOR), Jingjun Yan1 (AUTHOR), Chao Xia3 (AUTHOR), Yuanyuan Lin1 (AUTHOR), Xiaorui Jiang1 (AUTHOR), Haojing Liu1 (AUTHOR), Huanping Ren1 (AUTHOR), Junwei Yan1 (AUTHOR), Jusheng Lin1 (AUTHOR), Xingxing He1 (AUTHOR) xxhe@tjh.tjmu.edu.cn
Publikováno v:
Liver International. Nov2014, Vol. 34 Issue 10, p1532-1542. 11p. 3 Color Photographs, 1 Black and White Photograph, 1 Diagram, 1 Graph.
Publikováno v:
Tumor Biology. 36:55-67
Patients with hepatocellular carcinoma (HCC) usually present at advanced stages and do not benefit from surgical resection, so drug therapy should deserve a prominent place in unresectable HCC treatment. But chemotherapy agents, such as doxorubicin,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865370ca84a45498440200ef4946196c
https://doi.org/10.1007/s13277-014-2855-3
https://doi.org/10.1007/s13277-014-2855-3
Publikováno v:
Biological Research, Volume: 49, Pages: 1-9, Published: 2016
Biological Research
Biological Research, Vol 49, Iss 0, Pp 1-9
Biological Research v.49 2016
SciELO Chile
CONICYT Chile
instacron:CONICYT
Biological Research
Biological Research, Vol 49, Iss 0, Pp 1-9
Biological Research v.49 2016
SciELO Chile
CONICYT Chile
instacron:CONICYT
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a potentially devastating form of acute inflammatory lung injury as well as a major cause of acute respiratory failure. Although researchers have made significant progresses in elucidating the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6614f91aa5c17524e153e55671a5ff6
https://doi.org/10.1186/s40659-016-0085-4
https://doi.org/10.1186/s40659-016-0085-4
Autor:
Fang Liu, Haitao Shang, Xing-Xing He, Qian Dou, Yu-Nan Zhang, Jingjun Yan, Yuhu Song, Junwei Yan, Qiu Zhao
Publikováno v:
Scientific Reports
Reactivation of wild-type p53 (wt-p53) function is an attractive therapeutic approach to p53-defective cancers. An ideal p53-based gene therapy should restore wt-p53 production and reduces mutant p53 transcripts simultaneously. In this study, we desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860e1c50177f2f541baf123ac3caed09
Publikováno v:
Biological Research, Vol 49, Iss 0, Pp 1-9
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a potentially devastating form of acute inflammatory lung injury as well as a major cause of acute respiratory failure. Although researchers have made significant progresses in elucidating the
Externí odkaz:
https://doaj.org/article/a989e35a7e82478097c8aaae3a3d8c83